A Clinical trial to study the effect of the drug paandu legiam in patient having paandu noi(Iron deficiency anaemia).

PHASE II NON RANDOMIZED CLINICAL STUDY ON PAANDU NOI(IRON DEFICIENCY ANAEMIA)WITH EVALUATION OF SIDDHA TRIAL DRUGPAANDU LEGIYUM

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/029948

Enrollment

Registered

2020-12-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: D509- Iron deficiency anemia, unspecified

Interventions

Intervention1: Paandu legiyum: 2gm twice a day for 21 days after food Intervention2: Paandu legiyum: 2 gms of legiyum twice a day after food for 21 days Intervention3: paandu legiyum: 2 gm of legiyum

Eligibility

Inclusion criteria

Inclusion criteria: Hb 8 to 12gm/dl Pallor of skin mucous membrane nail bed lower palpabral conjuctiva Constipation Tiredness Generalised muscular weakness Poor school performance and lack of concentrate

Exclusion criteria

Exclusion criteria: Hb less than 8gm Known H/O Hemolytic anaemia Hereditary bleeding disorder i.e(Hemophilia) Patient with chronic disease i.e (Thalassemia,chronic malnutrition)

Design outcomes

Primary

Measure	Time frame
primary outcome is assessed by reduction of the clinical symptoms before and after treatmentTimepoint: 21 days	—

Secondary

Measure	Time frame
secondary outcome is assessed by comparing the safety parameters before and after treatmentTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDr Pushpavathi N

Government siddha medical college Chennai 106

ranimoorthybsms19@gmail.com9442286863

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026